367
Participants
Start Date
October 28, 2021
Primary Completion Date
May 15, 2024
Study Completion Date
May 15, 2024
BPZE1 pertussis vaccine and placebo
Live attenuated pertussis vaccine and placebo
BPZE1 pertussis vaccine and Boostrix
Live attenuated pertussis vaccine and tetanus, diphtheria, and aP vaccine
Placebo and Boostrix
Tetanus, diphtheria, and aP vaccine and placebo
Sydney Children's Hospital, Randwick
Sydney Children's Hospital, Westmead
Women's and Children's Hospital, North Adelaide
University of Melbourne, Melbourne
Telethon Kids Institute, Nedlands
CSA Clinica San Augustin, San José
IICIMED Instituto de Investigacion en Ciencias Medicas, San José
MRI, Metropolitan Research Institute, San José
Birmingham Children's Hospital NHS Foundation Trust, Birmingham
Bradford Royal Infirmary, Bradford
Bristol Royal Hospital For Children, Bristol
Addenbrooke's Hospital, Cambridge
Leicester Children's Hospital, Ward 14, Level 4,, Leicester
St George's Healthcare NHS Trust, London
Oxford Vaccine Group, Oxford
University Hospital Southampton NHS Foundation Trust, Southampton
Lead Sponsor
ILiAD Biotechnologies
INDUSTRY